Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have received a consensus rating of “Moderate Buy” from the seventeen ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Here are four perfect high-yield dividend stock picks for investors looking to follow the lead of the top money managers on ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...

Pfizer Inc. stands out as an undervalued biotech stock with strong dividend potential and ambitious oncology expansion. The company boasts a forward P/E of 8.82, making it significantly cheaper than ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...

This article compares the popular SCHX and SCHX exchange-traded funds and explains the best funds to invest in this year ...

While cash uses have exceeded cash flow recently, IPG's financial position remains solid. The firm ended 2024 with $3.0 billion in debt outstanding, excluding capitalized operating leases, and $2.2 ...

We’re in a somewhat unusual economic predicament right now. On one hand, inflation remains high (at least compared to the ...